Werbung
Werbung
MBRX
Moleculin Biotech, Inc.
3.95
USDGesponsert
-0.16
-3.82%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
3.88
-0.07
-1.85%
MBRX Ergebnisberichte
Positives Überraschungsverhältnis
MBRX übertreffen die 19 der letzten 33Schätzungen.
58%
Nächster Bericht
Datum des nächsten Berichts
19. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$7.92
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/-53.41%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-15.02%
Moleculin Biotech, Inc. earnings per share and revenue
On 13. Nov. 2025, MBRX reported earnings of -17.00 USD per share (EPS) for Q3 25, missing the estimate of -4.97 USD, resulting in a -241.88% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -7.92 USD, with revenue projected to reach -- USD, implying an decrease of -53.41% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Moleculin Biotech, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Moleculin Biotech, Inc. reported EPS of -$17.00, missing estimates by -241.88%, and revenue of $0.00, 0% as expectations.
How did the market react to Moleculin Biotech, Inc.'s Q3 2025 earnings?
The stock price moved down -4.43%, changed from $11.35 before the earnings release to $10.85 the day after.
When is Moleculin Biotech, Inc. expected to report next?
The next earning report is scheduled for 19. März 2026.
What are the forecasts for Moleculin Biotech, Inc.'s next earnings report?
Based on 4
analysts, Moleculin Biotech, Inc. is expected to report EPS of -$7.92 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung